Who owns Ocular Therapeutix, Inc.?
Institutional ownership of OCUL from SEC Form 13F filings across 181 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
181
13F holders
$1.29B
value, 2026 filers
63.9%
of shares outstanding (140.0M sh)
25
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of OCUL's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 32.8M | $322.5M | 0.0% | 15% | +0.6% |
| 2 | Deep Track Capital, LP | 19.7M | $193.3M | 2.8% | 9% | 0.0% |
| 3 | BlackRock, Inc. | 19.4M | $190.3M | 0.0% | 8.8% | +20.1% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 8.8M | $86.7M | 0.0% | 4% | -49.3% |
| 5 | PRICE T ROWE ASSOCIATES INC /MD/ | 7.6M | $74,864 | 0.0% | 3.5% | +29.3% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 5.0M | $49.3M | 0.0% | 2.3% | +10.9% |
| 7 | Point72 Asset Management, L.P. | 3.3M | $32.3M | 0.0% | 1.5% | -40.5% |
| 8 | Balyasny Asset Management L.P. | 2.3M | $22.3M | 0.0% | 1% | -15.7% |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.0M | $19.4M | 0.0% | 0.9% | +23.7% |
| 10 | NORTHERN TRUST CORP | 1.8M | $17.7M | 0.0% | 0.8% | +17.9% |
| 11 | GOLDMAN SACHS GROUP INC | 1.8M | $17.3M | 0.0% | 0.8% | +58.7% |
| 12 | Nuveen, LLC | 1.7M | $16.7M | 0.0% | 0.8% | +312.9% |
| 13 | Woodline Partners LP | 1.7M | $16.4M | 0.1% | 0.8% | -50.0% |
| 14 | TCG Crossover Management, LLC | 1.6M | $16.2M | 0.4% | 0.8% | 0.0% |
| 15 | UBS Group AG | 1.6M | $15.2M | 0.0% | 0.7% | +2.0% |
| 16 | ADAGE CAPITAL PARTNERS GP, L.L.C.NEW | 1.6M | $15.2M | 0.0% | 0.7% | new |
| 17 | Sixth Street Partners Management Company, L.P.NEW | 1.5M | $15.1M | 2.6% | 0.7% | new |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.5M | $15.1M | 0.0% | 0.7% | +4.9% |
| 19 | Squarepoint Ops LLC | 1.4M | $13.9M | 0.0% | 0.6% | +44.4% |
| 20 | Invesco Ltd. | 1.3M | $13.2M | 0.0% | 0.6% | -12.5% |
| 21 | VANGUARD FIDUCIARY TRUST CO | 1.3M | $12.7M | 0.0% | 0.6% | +3.5% |
| 22 | TWO SIGMA INVESTMENTS, LP | 1.2M | $12.0M | 0.0% | 0.6% | -33.4% |
| 23 | HRT FINANCIAL LP | 1.1M | $10,577 | 0.0% | 0.5% | +51.9% |
| 24 | RAYMOND JAMES FINANCIAL INC | 963,316 | $9.5M | 0.0% | 0.4% | +12.1% |
| 25 | MORGAN STANLEY | 911,831 | $9.0M | 0.0% | 0.4% | -28.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.